• Develop and execute personalized treatment plans for patients with hematologic malignancies and blood disorders by utilizing guideline recommendations based on the evaluation of molecular and phenotypic biomarkers, along with precise disease sub-classification.
• Assess the latest clinical trial data on novel agents and emerging strategies for newly diagnosed and relapsed or refractory disease states. 
• Discuss how to manage treatment-related adverse events through agent familiarity and robust monitoring efforts. 
• Engage medical students with the opportunity to hear from different oncology professionals on ways they can adjust their practice to serve more underserved communities.

Desired Outcome

The goal of the 2026 Annual Updates in Hematology Symposium is to provide participants with information to improve patient management and care strategies. This goal will be accomplished by discussing rapidly evolving developments and improved practice paradigms. The symposium will provide learners with enhanced knowledge of evidence-based data related to best practices for treating select blood cancers and disorders and inform them of the indications to refer patients for expert quaternary-level care. Panel discussions, along with question-and-answer sessions that include collaborative sharing of information and research, as well as networking with other healthcare professionals have shown to improve participant knowledge and competency. Additionally, it will build a connected community of hematological care providers across the region.